Will be interesting to see how much the EBITDA needs to be guided down on the back of this morning's announcement - i'd thought of EoN as more a 2021-2023 type prospect based on slide 10 of their FY19 results presentation, and they shouldn't have been aggressively forecasting new sales given market conditions. I suppose there's now some reasonable doubt about whether EoN will ever be rolled out.
NZ-listed stock (off 25%) now trades at ~3.5x EV / recurring revenue. Will be interesting to see whether any directors/managers buy stock on open market at these levels - they absolutely should if the current issues are truly transitory (which is what they're publicly saying).
- Forums
- ASX - By Stock
- GTK
- Ann: Director Resignation and Appointment. Resignation of CFO.
Ann: Director Resignation and Appointment. Resignation of CFO., page-12
-
- There are more pages in this discussion • 17 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add GTK (ASX) to my watchlist
(20min delay)
|
|||||
Last
$9.30 |
Change
0.070(0.76%) |
Mkt cap ! $955.2M |
Open | High | Low | Value | Volume |
$9.30 | $9.34 | $9.19 | $212.5K | 22.92K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 418 | $9.28 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$9.31 | 2085 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
5 | 170 | 9.310 |
1 | 23 | 9.300 |
3 | 700 | 9.290 |
1 | 160 | 9.280 |
3 | 1331 | 9.270 |
Price($) | Vol. | No. |
---|---|---|
9.330 | 77 | 2 |
9.340 | 195 | 2 |
9.350 | 7151 | 2 |
9.360 | 910 | 2 |
9.370 | 581 | 2 |
Last trade - 10.54am 04/07/2024 (20 minute delay) ? |
Featured News
GTK (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham, CEO
James Graham
CEO
Previous Video
Next Video
SPONSORED BY The Market Online